AI-generated summary
The authors compared markers of protein oxidative modification in blood serum of patients with rheumatoid arthritis-associated secondary osteoarthrosis with healthy subjects, and assessed changes in patients given combined drug therapy plus low-intensity laser irradiation versus drug therapy alone. They report higher oxidative modification markers in patients than in healthy subjects, and a greater reduction of pain scores and these markers in the laser-treated group.
- Who or what was studied
- Patients with rheumatoid arthritis associated with secondary osteoarthrosis (n = 50, split into two groups of 25) and healthy subjects (n = 25)
- Limits stated in the abstract
- The abstract does not report the laser wavelength or the statistical details, and the description of the two subgroups is internally inconsistent.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on mediasphera.ru.
Record from PubMed, a service of the National Library of Medicine.
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Laser, Visual analogue scale, Oxidative stress, Osteoarthritis. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.